ArticleFrontiers in pediatrics2026
Downregulation of alcohol dehydrogenase family proteins suggests disrupted retinol metabolism in neonatal respiratory distress syndrome: an umbilical cord blood proteomics study.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Neonatal respiratory distress syndrome (NRDS) is a prevalent complication in preterm infants, characterized by severe pulmonary dysfunction and elevated mortality rates. To systematically profile the umbilical cord blood proteome in neonates with NRDS, aiming to identify and explore their potential pathological mechanisms. Methods: A case-control study was conducted, enrolling 60 preterm infants (< 34 weeks gestational) born between November 2024 and October 2025, including 32 NRDS cases and 28 matched controls. Umbilical cord blood plasma was analyzed via nanomaterial-based low-abundance protein enrichment (n_LAPE) and liquid chromatography-tandem mass spectrometry (LC-MS/MS) in data-independent acquisition mass spectrometry (DIA) mode. Differentially expressed proteins (DEPs) were identified using the Limma package. Bioinformatics analyses included Gene Ontology (GO), KEGG pathway enrichment, protein-protein interaction (PPI) network construction, and gene set enrichment analysis (GSEA). The Least Absolute Shrinkage and Selection Operator (LASSO) regression and Random Forest algorithm were employed to screen for core proteins and evaluate their discriminatory potential. Results: A total of 7,529 high-confidence proteins were identified (5,090 passed quantification filters and entered differential expression analysis), with 157 DEPs between groups. These DEPs were significantly enriched in retinol metabolism, and complement and coagulation cascades. Both PPI network and GSEA analyses consistently highlighted the downregulation of alcohol dehydrogenase (ADH) family proteins (ADH1A, ADH1B, ADH4, ADH6) as the most prominent differential feature. An exploratory model based on five proteins, including ADH4, yielded AUCs of 0.982 (95% CI 0.95-1.00) and 0.838 (95% CI 0.63-1.00) in the training and test sets, respectively. Conclusion: The umbilical cord blood proteome of NRDS neonates is significantly disrupted, characterized by the downregulation of ADH family proteins. This suggests that ADH downregulation may contribute to NRDS pathogenesis by interfering with retinol metabolism, offering a novel mechanistic perspective. While the exploratory discriminatory model shows promise, it requires validation in large-scale prospective cohorts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.